Drinking history does not affect HCV therapy success, study finds

10/15/2012 | PhysiciansBriefing.com

Prior alcohol consumption patterns do not significantly affect the success of hepatitis C treatment using pegylated interferon-alpha and ribavirin, according to research from the Pacific Institute for Research and Evaluation in California. Data showed regardless of drinking history, 45.1% of those with HCV genotype 1, 4 or 6 and 80.2% of patients with genotype 2 or 3 achieved a sustained virological response to the combination treatment.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD